The IRB has a federally mandated responsibility to protect human subjects involved in research. The efforts and expertise required to achieve this are substantial.
Below is the Fee Schedule for Protocol Submission and subsequent IRB action.
Initial Review: A $2,000 fee covers the cost of reviewing the protocol, informed consent document, investigator's brochure, any advertisements and translations, as well as amendments, administrative letters, and serious adverse events.
Annual Review: A $500 fee per year covers any action required following the initial review, i.e., annual review, reporting of adverse events and all other communication.
Payment is expected independent of the IRB decision and is due within 30 days of receipt of invoice. This fee may be waived for non-commercially sponsored studies at the discretion of the IRB office.
|
|